Ginkgo Bioworks Holdings, Inc. Chief Financial Officer Steven P. Coen reported a recent change in his ownership of the company’s Class A common stock tied to vesting of equity awards. On July 16, 2026, Coen disposed of 1,174 shares of Ginkgo Class A common stock at a reported price of $3.12 per share. The transaction was reported under transaction code “F,” which is commonly used for shares withheld or sold to satisfy tax withholding obligations. Based on the reported price, the sale represented roughly $3,663 in value. After the transaction, Coen beneficially owned 51,878 shares of Class A common stock. The filing states that the sale was a “sell to cover” transaction made to fund tax withholding obligations arising from the vesting of restricted stock and/or restricted stock units, or RSUs. The company emphasized in the explanatory notes that these sales do not represent discretionary trades by Coen. Ginkgo’s equity incentive plans permit the company to require tax withholding obligations to be satisfied through such sell-to-cover transactions. The filing also describes Coen’s RSU awards. Each RSU represents a contingent right to receive one share of Ginkgo’s Class A common stock. One RSU award vests 25% of the underlying shares on May 1, 2024, followed by 36 equal monthly installments. Another RSU award vests 2/48ths of the underlying shares on May 1, 2024, followed by 46 equal monthly installments. The document also references RSU-related holdings of 52,190 shares and a reported per-share figure of $7.52, with the explanatory notes focused on vesting mechanics rather than an open-market purchase. The Form 4 was signed on July 20, 2026, by Karen Tepichin as attorney-in-fact for Coen. The filing identifies Coen as Ginkgo’s Chief Financial Officer and reports the activity as an insider ownership change involving the company’s Class A common stock.